*ncbi.life
			MedGen

  Source:		MedGen UID: 52963


     		Vaccine

			Definition
			Preparations containing substances with
			antigenic properties administered to activate
			the immune system, thereby inducing an
			immune response.

			Related Concepts
			Ad-sig-hMUC-1/ecdCD40L Vaccine
			Adenoviral Brachyury Vaccine ETBX-051
			Adenoviral MUC1 Vaccine ETBX-061
			Adenovirus-PSA Prostate Cancer Vaccine
			Adverse Event Following Immunization
			AE37 Peptide/GM-CSF Vaccine
			AIDS Vaccines
			Algenpantucel-L
			Allogeneic Cellular Vaccine 1650-G
			Allogeneic Melanoma Vaccine AGI-101H
			Allogeneic Tumor Cell Vaccine
			Allogenic Glioma Cancer Vaccine
			Alpha Fetoprotein Plasmid DNA Vaccine
			Alpha-type-1 Polarized Dendritic Cells
			Aluminum hydroxide
			Aluminum Sulfate Anhydrous
			ALVAC-B7-CEA
			ALVAC-CEA B7.1 Vaccine
			ALVAC-CEA Vaccine
			ALVAC-ESO-1 Vaccine
			ALVAC-hB7.1
			ALVAC-MART-1 Vaccine
			Alzheimer Vaccines
			Amolimogene Bepiplasmid
			Amyloid Beta-Peptide Pathway
			Anthrax vaccine
			Anti-Idiotype Vaccine
			Anti-OFA Immunotherapeutic BB-MPI-03
			antileprosy vaccine
			Antineoplastic Vaccine
			APC Vaccine
			APC8015 Vaccine
			APC8015F
			AS02A
			AS04 Adjuvant
			Astuprotimut-R
			Attenuated Corynebacterium Parvum
			Attenuated Live Vaccine
			Attenuated Live Virus Vaccine
			AUT-OV-ALVAC-hB7.1 Vaccine
			Autologous Colon Cancer Cell Vaccine
			Autologous Dinitrophenyl Vaccine
			Autologous IL-2-expressing B-CLL Vaccine
			Autologous Tumor Cell Vaccine
			Autologous-Cell Leukemia Vaccine
			Autologous-Cell Melanoma Vaccine
			B16alphaGal Melanoma Vaccine
			B7 Transfected Melanoma Cell Vaccine
			Bacterial vaccine
			Bacteriophage phi X 174 Vaccine
			Baculovirus CEA Protein Vaccine
			BCG Tokyo-172 Strain Solution
			BCG Tokyo-172 Strain Vaccine
			Bcl-Xs Adenovirus Vaccine
			Berzofsky Ras/P53 Peptide Vaccine
			Bordetella pertussis Vaccine Adsorbed
			Brain Tumor Initiating Cell Vaccine
			Canarypox-hIL-12 Melanoma Vaccine
			CCL21-expressing H1944 Cell Vaccine
			CD3/CD28 Costimulated Autologous T-Cells
			CD80 Breast Cancer Vaccine
			CEA-MUC-1-TRICOM Vaccine CV301
			Cholera vaccine
			CHP-NY-ESO-1 Peptide Vaccine IMF-001
			CMV N495 Peptide
			CMVpp65-A*0201 Peptide Vaccine
			Conjugate Vaccine
			CTP-37-DT Vaccine
			Cytomegalovirus Vaccines
			D1/3-Mage-3-His Fusion Protein
			Dendritic Cell Tumor Cell Lysate Vaccine
			Dendritic Cell Tumor Peptide Vaccine
			Dendritic Cell Vaccine
			Dendritic Cell-CEA Peptide Vaccine
			Dendritic Cell-MART-1 Peptide Vaccine
			Dengue Vaccines
			DEPDC1/MPHOSH1 Peptide Vaccine
			Detox
			Detox-B Adjuvant
			dHER2 Vaccine+AS15 Adjuvant
			Dinitrophenyl
			Diphtheria + tetanus vaccine
			DNA Vector pPRA-PSM Vaccine
			DPX-E7 HPV Vaccine
			Ebola Vaccines
			Escherichia coli Vaccines
			Ethylchlorformate Vaccine
			eVLP CMV gB-pp65 Plus GM-CSF VBI-1901
			Falimarev
			Fowlpox Virus Vaccine
			Fowlpox Virus Vaccine Vector
			Fowlpox-NY-ESO-1 Vaccine
			Fowlpox-PSA-TRICOM Vaccine
			FPV Vaccine CV301
			G250 Peptide Vaccine
			Gastrin Immunotoxin
			GD2-KLH Vaccine
			GI-4000 Vaccine
			Glioblastoma Cancer Vaccine ERC1671
			Glioma Lysate Vaccine GBM6-AD
			Globo H-DT Vaccine OBI-833
			GM-K562 Cell Vaccine
			GM.CD40L Cell Vaccine
			GM2-KLH Vaccine
			gp100 Adenovirus Vaccine
			gp100 and GM-CSF DNA/Gold Vaccine
			gp100 Antigen
			gp100 cDNA/Gold Complex
			gp100 Vaccinia Vaccine
			gp100-Fowlpox Vaccine
			GP2 Peptide/GM-CSF Vaccine
			GPI-0100
			GVAX Lung Cancer Vaccine
			GVAX Pancreatic Cancer Vaccine
			H3.3K27M-specific Peptide Vaccine
			Haemophilus Influenzae B Vaccine
			Haemophilus Vaccines
			Hepatitis A Vaccine
			Hepatitis A virus vaccine
			Hepatitis B Vaccine
			HER-2/neu Peptide Vaccine
			Herpes Simplex Virus Vaccines
			Herpes Zoster Vaccine GSK1437173A
			Herpesvirus Vaccines
			HIV p24 antigen
			HIV Peptide Vaccine
			HIV Vaccine
			HPV 16 L1-VLP
			HPV-11 Vaccine
			hTERT Vaccine V934/V935
			hTERT/Survivin/CMV Multipeptide Vaccine
			Human gp100 Plasmid DNA Vaccine
			Human papillomavirus vaccine
			Human Papillomavirus Vaccine V503
			hVEGF26-104/RFASE Peptide Vaccine
			Hypotonic-Hyporesponsive Episode
			IMT-1012 Immunotherapeutic Vaccine
			Inactivated Vaccinia Virus
			Inalimarev
			Incomplete Freund Adjuvant
			Influenza virus vaccine
			Interleukin-2 Anti-Idiotype Vaccine
			Interleukin-2 Liposome
			ISCOMs
			IVAC Mutanome Vaccine
			K-RAS ASP-13 Mutant Protein
			K-RAS GLY-12 Mutant Protein
			K-RAS Protein Vaccine
			K-RAS VAL-12 Mutant Protein
			KLH-Lymphoma Ig Vaccine
			KRAS CYS-12 Mutant Protein
			Lapuleucel-T
			Leishmaniasis Vaccines
			Liposomal MUC1/PET-lipid A Vaccine
			Live Attenuated Influenza Vaccine
			Live zoster virus vaccine
			Lyme disease vaccine
			Macrophagic myofasciitis
			MAG-Tn3/AS15 Vaccine
			MAGE-1 Vaccinia Contaminated with BVDV
			MAGE-12 Peptide Vaccine
			MAGE-3 Peptide Vaccine
			MAGE-A3 Multipeptide Vaccine GL-0817
			MAGE-A3 Peptide Vaccine
			MAGE-A3/HPV 16 Peptide Vaccine
			Mammaglobin-A DNA Vaccine
			Marek Disease Vaccines
			MART-1 Adenovirus Vaccine
			MART-1 Fowlpox Vaccine
			MART-1 Vaccinia Vaccine
			Measles vaccine
			Melan-A VLP Vaccine
			Melan-A/MAGE-3.DP4 Peptide Vaccine
			Melanoma Helper Peptide Vaccine
			Melanoma Theraccine
			Melanoma TRP2 CTL Epitope Vaccine SCIB1
			Melanoma vaccine
			MELITAC 12.1 Peptide Vaccine
			Meningococcus vaccine
			MGV Vaccine
			Mimotope-P10s-PADRE Peptide Vaccine
			Mixed Bacteria Vaccine
			Monophosphoryl Lipid A
			Montanide ISA 51 VG
			Montanide ISA 720
			Montanide ISA-51
			Mouse gp100 Plasmid DNA Vaccine
			mRNA-derived Lung Cancer Vaccine CV9202
			MUC-1 Peptide Vaccine
			MUC1 Peptide-Poly-ICLC Vaccine
			Multi-epitope Melanoma Peptide Vaccine
			Multipeptide Vaccine S-588210
			Mumps vaccine
			Mutated Ras Peptide
			MVA-EBNA1/LMP2 Vaccine
			MVA-FCU1 TG4023
			MVA-MUC1-IL2 Vaccine
			MVA-PSA/PAP Prostate Cancer Vaccine
			Myeloma Ig Id-KLH Conjugate Vaccine
			
			NA-17/MAGE-3.A2/NY-ESO-1 Peptide Vaccine
			NA17-A Antigen
			Nelipepimut-S
			Neoantigen Peptide
			Neoantigen-based Glioblastoma Vaccine
			Neoantigen-HSP70 Peptide Cancer Vaccine
			NY-ESO-1 Peptide Vaccine
			NY-ESO-1/GLA-SE Vaccine ID-G305
			NY-ESO-1/LAGE-1 Peptide Vaccine
			Oncovax-ID/IL-2 Vaccine
			Ovapuldencel-T
			Ovarian Cancer Peptide Vaccine
			p53 Peptide Vaccine
			PA-1-STK Ovarian Carcinoma Vaccine
			PADRE-CMV Fusion Peptide Vaccine
			Papillomavirus Vaccines
			PCLUS 3-18MN
			PCLUS 6.1-18MN
			Pentavalent KLH Conjugate Vaccine
			PEP-3-KLH Conjugate Vaccine
			Peptide Vaccine
			Peripheral Blood Lymphocyte Vaccine
			Personalized Cancer Vaccine RO7198457
			Personalized Genomic Vaccine 001
			Pneumococcal 10-valent Conjugate Vaccine
			Pneumococcal conjugate vaccine
			pNGVL3-hICD Vaccine
			Poliovirus vaccine
			Polyclonal Vaccine
			Polysaccharide Vaccine
			Polysialic Acid
			Polyvalent Antigen-KLH Conjugate Vaccine
			Polyvalent Melanoma Vaccine
			Polyvalent Vaccine
			PR1 Leukemia Peptide Vaccine
			Prime Cancer Vaccine MVA-BN-CV301
			Prostate Cancer Vaccine ONY-P1
			PSA-OP Peptide Vaccine
			PSA/IL-2/GM-CSF Vaccine
			Pseudomonas Vaccines
			Pseudoprogression
			Pseudorabies Vaccines
			PSMA/TARP Peptide Vaccine
			pTVG-HP Plasmid DNA Vaccine
			pVAXrcPSAv53l DNA Vaccine
			QS21
			Rabies vaccine
			RAS Peptide Cancer Vaccine
			RASVAC-C
			RASVAC-V
			Recombinant CD40-Ligand
			Recombinant dHER2 Vaccine
			Recombinant Fowlpox-B7.1 Vaccine
			Recombinant Fowlpox-Mgp100 Vaccine
			Recombinant Fowlpox-TRICOM Vaccine
			Recombinant Vaccinia DF3/MUC1 Vaccine
			Recombinant Vaccinia PSA Vaccine
			Recombinant Vaccinia-B7.1 Vaccine
			Recombinant Vaccinia-MUC-1 Vaccine
			Recombinant Vaccinia-NY-ESO-1 Vaccine
			Recombinant Vaccinia-TRICOM Vaccine
			Recombinant Viral Vaccine
			Resiquimod
			Respiratory Syncytial Virus Vaccines
			Rickettsial vaccine
			Rilimogene Galvacirepvec
			Rindopepimut
			rMVA-PSA/PSMA/TRICOM
			Rubella and mumps vaccine
			Rubella vaccine
			SAIDS Vaccines
			Salmonella Vaccines
			Saponin-based Immunoadjuvant OBI-821
			Sargramostim Plasmid DNA Sarcoma Vaccine
			SB AS-2
			SB-AS02B Adjuvant
			SB-AS15 Adjuvant
			Severe myoclonic epilepsy in infancy
			SGN-00101
			Shigella Vaccines
			Sipuleucel-T
			Smallpox vaccine
			STn-KLH plus Detox Vaccine
			Streptococcal Vaccines
			Survivin Antigen Vaccine DPX-Survivac
			Synthetic Vaccine Particles-Rapamycin
			TARP 27-35 Peptide Vaccine
			TARP 29-37-9V Peptide Vaccine
			TBC-CEA-Contaminated W/ BVDV
			Tetanus Peptide Melanoma Vaccine
			Tetanus toxoid adsorbed product
			Tetanus Toxoid Helper Peptide
			Tetanus-CMV Fusion Peptide Vaccine
			Tetravalent RNA-lipoplex Cancer Vaccine
			Theramide
			Thimerosal product
			TLR Agonist CADI-05
			TLR4 Agonist GSK1795091
			Toxoid Vaccine
			Trivalent Influenza Vaccine
			Tuberculosis vaccine
			Tumor Cell Derivative Vaccine
			Tumor Cell-derived Dribbles Vaccine
			Ty21a Typhoid Vaccine
			Typhoid-paratyphoid vaccine
			Unconjugated Lymphoma Ig Id
			Unconjugated Myeloma Ig Id
			URLC10 Peptide Vaccine
			URLC10-CDCA1-KOC1 Multipeptide Vaccine
			UV1 Telomerase Peptide Vaccine
			V930 Vaccine
			Vaccinated
			Vaccine Antigen
			Vaccinia
			Vaccinia CEA Vaccine
			Vaccinia-Tyrosinase Vaccine
			Varicella-zoster live attenuated vaccine
			Varlilumab
			VCL-CB01 Vaccine
			VEGFR-2 DNA Vaccine VXM01
			Verpasep Caltespen
			Viral Hepatitis Vaccines
			Viral vaccine
			Vitespen
			Von Hippel-Lindau Peptide Vaccine
			West Nile virus vaccine
			Whole Cell Vaccine
			WT1 Peptide Vaccine OCV-501
			WT1 Peptide Vaccine WT2725
			antibody
			immunization
			influenza
			influenza
			papilloma
			cancer
			measles
			peptide
			effectiveness
			SARS-CoV-2
			antiviral
			COVID-19
			severe acute respiratory syndrome
			influenza vaccination

			BioProject
			PRJNA271578 A Cell-based Systems Biology
			Assessment of Human Blood to Monitor
			Immune Responses After Influenza Vaccination

			PRJNA128389 A cryptic sensor for HIV-1
			activates antiviral innate immunity in dendritic
			cells

			PRJNA301139 A novel tumor-associated
			myeloid cell population inhibits antigen-specific
			immune responses in cancer patients

			PRJNA302281 A novel tumor-associated
			myeloid cell population inhibits antigen-specific
			immune responses in cancer patients

			PRJNA384259 A third generation therapeutic
			vaccine for human visceral leishmaniasis and
			post kala azar dermal leishmaniasis:
			first-in-human trial of ChAd63-KH

			PRJNA109591 Ad-HER-wt and Ad-HER2-ki
			infected HMECs

			PRJNA389396 Adenosine DeAminase-1
			(ADA-1) improves Follicular helper T cell
			function and vaccine response [1]

			PRJNA389590 Adenosine DeAminase-1
			(ADA-1) improves Follicular helper T cell
			function and vaccine response [2]

			PRJNA397768 Adjuvant associated
			peripheral-blood mRNA profiles and kinetics
			induced by the adjuvanted recombinant-protein
			candidate tuberculosis vaccine M72/AS01 in
			BCG-vaccinated adults

			PRJNA211844 Adult Influenza Vaccine
			Genetics

			PRJNA211845 Adult Influenza Vaccine
			Genetics

			PRJNA311327 Affect of Interferon Gamma on
			Chordoma Cells

			PRJNA343738 An atlas of B cell clonal
			distribution in the human body

			PRJNA339129 Analysis of DC vaccines used
			for phase II clinical trial in prostate carcinoma
			patients

			PRJNA298937 Analysis of Genetic Factors in
			Melanoma-Antigen Discovery

			PRJNA412243 Anti-mycobacterial activity
			correlates with altered DNA methylation pattern
			in immune cells from BCG-vaccinated subjects

			PRJNA323735 Antibody mRNA sequencing
			after vaccination with H3N2 variant vaccine

			PRJNA342469 Antibody profile in patients with
			mild and severe leptospirosis

			PRJNA324093 B cell repertoire sequencing of
			seasonal influenza vaccine responses

			PRJNA179248 Baseline serum anti-glycan
			antibodies of 113 subjects in a clinical trial of
			PROSTVAC-VF, a therapeutic cancer vaccine
			[Validation IgG 1:50]

			PRJNA179249 Baseline serum anti-glycan
			antibodies of 113 subjects in a clinical trial of
			PROSTVAC-VF, a therapeutic cancer vaccine
			[Validation IgM 1:50]

			PRJNA179251 Baseline serum anti-glycan
			antibodies of 113 subjects in a clinical trial of
			PROSTVAC-VF, a therapeutic cancer vaccine
			[Validation Total Ig 1:200]

			PRJNA179250 Baseline serum anti-glycan
			antibodies of 113 subjects in a clinical trial of
			PROSTVAC-VF, a therapeutic cancer vaccine
			[Validation Total Ig 1:50]

			PRJNA179244 Baseline serum anti-glycan
			antibodies of 28 subjects in a clinical trial of
			PROSTVAC-VF, a therapeutic cancer vaccine
			[Training IgG 1:50]

			PRJNA179245 Baseline serum anti-glycan
			antibodies of 28 subjects in a clinical trial of
			PROSTVAC-VF, a therapeutic cancer vaccine
			[Training IgM 1:50]

			PRJNA179247 Baseline serum anti-glycan
			antibodies of 28 subjects in a clinical trial of
			PROSTVAC-VF, a therapeutic cancer vaccine
			[Training Total Ig 1:200]

			PRJNA179246 Baseline serum anti-glycan
			antibodies of 28 subjects in a clinical trial of
			PROSTVAC-VF, a therapeutic cancer vaccine
			[Training Total Ig 1:50]

			PRJNA217428 Baseline serum anti-glycan IgM
			antibodies of 113 subjects in a clinical trial of
			PROSTVAC-VF, a therapeutic cancer vaccine.
			(Dilution = 1:50)

			PRJNA217431 Baseline serum anti-glycan total
			Ig antibodies of 113 subjects in a clinical trial of
			PROSTVAC-VF, a therapeutic cancer vaccine.
			(Dilution = 1:50)

			PRJNA308641 BCR repertoire sequencing in
			humans following Hepatitis B booster
			vaccination

			PRJNA308566 BCR repertoire sequencing in
			humans following Hepatitis B primary
			vaccination

			PRJNA244426 BDCA1+ mDCs and BDCA3+
			mDCs stimulated with vaccines for 6 hr

			PRJNA123919 Blood Transcriptional Profiles in
			Active and Latent Tuberculosis UK (Training
			Set)

			PRJNA271396 Blood transcriptomes of chronic
			HCV patients four years after therapy-induced
			viral clearance

			PRJNA315119 CCL4 Secretion By
			Interleukin-15 Dendritic Cells Directs Superior
			Recruitment Of Cd56+ Cytolytic Lymphocytes

			PRJNA512522 CD56dim NK cell gene
			signature in melanoma patients with better and
			worse clinical outcomes

			PRJNA196147 Changes in gene expression
			profiles of circulating B cells after influenza
			vaccination in healthy human subjects

			PRJNA421015 Characterization of gene
			expression in antibody secreting cells

			PRJNA411822 Characterization of
			rubella-specific humoral immunity following two
			doses of MMR vaccine using proteome
			microarray technology

			PRJNA396773 Common HIV-1 escape
			patterns drive the maturation of V2-Apex
			broadly neutralizing antibodies

			PRJNA114563 Comparison of CD4+ T cell
			function between HIV-1 resistant and HIV-1
			susceptible individuals (Affymetrix)

			PRJNA114565 Comparison of CD4+ T cell
			function between HIV-1 resistant and HIV-1
			susceptible individuals (Immune)

			PRJNA193608 Comparison of M. tuberculosis
			and M. bovis BCG in diluted whole blood
			cultures

			PRJNA98565 Comparison of the costimuli
			anti-CD28 and IL-2 on the activation of purified
			naïve human T cells

			PRJNA189193 Comparison of transcriptional
			profiles of PBMCs from HIV-infected rapid
			progressors and chronic progressors

			PRJNA407885 Comprehensive understanding
			of identities and antigenicities of surface and
			secreted proteins in Toxoplasma gondii
			tachyzoites

			PRJNA274307 Constitutively-active MAVS
			inhibits HIV-1 replication via type I interferon
			secretion and induction of HIV-1 restriction
			factors

			PRJNA355641 Correlates of self-reported
			symptom scores in a human H1N1 influenza
			challenge trial

			PRJNA171005 Cytokine and gene transcription
			profiles of immune responses elicited by HIV
			lipopeptide vaccine in HIV-negative volunteers

			PRJNA202208 DALIA-1 Whole Blood
			Longitudinal Gene Expression

			PRJNA158303 DC populations incubated with
			rAd5, rAd28, rAd35, TLR7/8-ligand, or
			unexposed

			PRJNA106981 Dendritic Cell Vaccine against
			Glioblastoma Multiforme Patients

			PRJNA106649 Dendritic cells activated with
			LPS IFNg over 48 hours

			PRJNA480690 Dengue virus-specific CD8 T
			cell subsets are associated with specialized
			gene expression profiles and TCR repertoires

			PRJNA429049 Differential miRNA Expression in
			B Cells/T Cells Associated with Inter-individual
			Differences in Humoral Immune Response to
			Measles Vaccination

			PRJNA295083 Down-regulation of Interferon
			signature in systemic lupus erythematosus
			patients by active immunization with Interferon
			alpha-Kinoid extended follow-up

			PRJNA306644 Effect of human DAI expressed
			by an oncolytic vaccinia virus on the gene
			expression of tumor cells (HS294T) and
			monocytes (THP-1).

			PRJNA312717 Epigenetic Analysis of
			Malnutrition

			PRJNA312718 Epigenetic Analysis of
			Malnutrition

			PRJNA411820 Epigenomes and
			transcriptomes of human monocytes before
			and after in vivo exposure to Bacillus
			Calmette-Guérin vaccine

			PRJNA325294 Evaluation of the
			immunogenicity of live-attenuated influenza
			vaccines in nasal epithelial cells in primary
			differentiated human nasal epithelial cells
			[Microarray Expression]

			PRJNA323488 Evaluation of the
			immunogenicity of live-attenuated influenza
			vaccines in nasal epithelial cells in primary
			differentiated human nasal epithelial cells
			[RNA-Seq]

			PRJNA117977 Expression data from a malaria
			vaccine trial (HG-U133A2.0 and U133 Plus 2.0)

			PRJNA394897 Expression data from different
			levels of ANA in HIV+ people

			PRJNA432157 Expression data from different
			levels of anti-CD4 in HIV+ people

			PRJNA270766 Expression data from whole
			blood samples of Rwandan adults with mild
			malaria with matched sample thirty days later
			(convalescence)

			PRJNA324186 Expression data from Yellow
			Fever 17D vaccine immunized healthy subjects

			PRJNA390771 Expression profile of
			microRNAs in serum extracellular vesicles
			isolated from 6 healthy subjects

			PRJNA153827 FACS-sorted cells from Young
			Adults Vaccinated with Influenza TIV or LAIV
			Vaccines during 2008/09 Flu Season

			PRJNA493159 Field studies of
			Cryptosporidiosis and Enteropathogens in
			Bangladesh

			PRJNA272412 Functional heterogeneity of
			human memory T cell clones primed by
			pathogens or vaccines

			PRJNA96239 Gene Expression Analysis in
			Malaria Infection

			PRJNA256010 Gene expression analysis of
			Influenza vaccine response in Young and Old -
			Year 1 - PBMC

			PRJNA256009 Gene expression analysis of
			Influenza vaccine response in Young and Old -
			Year 2 - PBMC

			PRJNA256094 Gene expression analysis of
			Influenza vaccine response in Young and Old -
			Year 3 - PBMC

			PRJNA174748 Gene expression analysis of
			peripheral blood mononuclear cells prior to and
			following vaccination of human volunteers with
			the novel TB vaccine candidate MVA85A

			PRJNA253051 Gene expression and cytokine
			profile correlate with mycobacterial growth in a
			human BCG challenge model

			PRJNA159947 Gene expression data from F.
			tularensis-exposed neutrophils

			PRJNA505415 Gene expression data of
			glioblastoma patients from GAPVAC trial
			(Glioma Actively Personalized Vaccine
			Consortium)

			PRJNA516645 Gene expression for surgically
			treated pancreatic cancer after one
			neoadjuvant vaccine dose

			PRJNA110693 Gene Expression Patterns
			Induced by HPV-16 L1 VLP in Leukocytes from
			Vaccine Recipients

			PRJNA422122 Gene expression profiles
			associated with humoral response to influenza
			vaccine, Vaxigrip, in young and elderly subjects
			of Chinese ethnicity in Singapore

			PRJNA281712 Gene expression profiling of
			B-cell and non-B-cell fractions of follicular
			lymphoma

			PRJNA513089 Gene expression signatures
			after immunisation with a range of live,
			inactivated and adjuvanted vaccines
			(BIOVACSAFE protocols 305A, 305B and
			305C)

			PRJNA341468 Gene expression signatures in
			activated CD4 T cells to predict_vaccine
			responses

			PRJNA341467 Gene expression signatures in
			whole blood to predict vaccine responses

			PRJNA106893 Gene-expression profiles of
			non-tumor-reactive CD8+ T cells

			PRJNA80941 Genome Variation among
			HIV-Resistant People with Hemophilia

			PRJNA80943 Genome Variation among
			HIV-Resistant People with Hemophilia

			PRJNA436088 Genome-Wide CRISPR/Cas9
			Screen Identifies Host Factors Essential for
			Influenza Virus Replication

			PRJNA144025 Genome-wide profiling of whole
			blood from healthy adult volunteers before and
			after receiving non-live vaccines including
			seasonal influenza or pneumococcal vaccine or
			placebo (saline) injections I

			PRJNA211783 Genome-wide profiling of whole
			blood from healthy adult volunteers before and
			after receiving non-live vaccines including
			seasonal influenza or pneumococcal vaccine or
			placebo (saline) injections II

			PRJNA236610 Genomic Fingerprints of DC
			Subsets in the Human Vaginal Mucosa, Skin,
			and Blood

			PRJNA223296 GEP of PMBCs during
			treatment with a gene-modified allogeneic
			tumor cell vaccine in advanced renal cell cancer
			(RCC) patients

			PRJNA264572 Global analyses revealed
			age-related alterations in innate immune
			responses after stimulation of
			pathogen-recognition receptors

			PRJNA285808 Gut microbiome composition is
			associated with malaria infection risk

			PRJNA493153 Gut Microbiome Sequencing of
			Head and Neck Cancer Patients

			PRJNA491676 HantavaxTM vaccinated
			peripheral blood mononuclear cells (PBMCs)
			and sera analyses by transcriptomic and
			metabolomic profilings

			PRJNA352224 Harnessing RNA sequencing for
			global, unbiased evaluation of two new
			adjuvants for dendritic-cell immunotherapy

			PRJNA317685 Heavy chain antibody
			sequencing from naive donors used in study,
			"Vaccine-Induced Antibodies that Neutralize
			Group 1 and 2 Influenza A Viruses"

			PRJNA490197 HiSeq analysis of human gene
			expression profile following infection with highly
			pathogenic avian influenza A virus (H5N1;
			A/Chicken/Vietnam/0008/04)

			PRJNA294582 Homo sapiens PBMCs:
			pre-vaccination (stimulation vs. no stimulation
			with EV71 antigen) vs. post-vaccination
			(stimulation vs. no stimulation with EV71
			antigen)

			PRJNA407499 Homo sapiens Phenotype or
			Genotype

			PRJNA339664 Homo sapiens Raw sequence
			reads(HBV vaccine repertoires)

			PRJNA382800 Host transcription profile in
			nasal epithelium and blood of hospitalized
			children under two years old with Respiratory
			Syncitial Virus infection [nasopharyngeal swaps]

			PRJNA382801 Host transcription profile in
			nasal epithelium and blood of hospitalized
			children under two years old with Respiratory
			Syncitial Virus infection [whole blood]

			PRJNA205206 Human antibody heavy chain
			repertoires in dengue

			PRJNA270742 Human B cell immunoglobulin
			repertoire analysis following West Nile Virus
			infection

			PRJNA184857 Human CD1c+ dendritic cells
			drive the differentiation of CD103+ CD8+
			mucosal T cells via TGF-β

			PRJNA105797 Human Dendritic Cell Subtype
			Gene Arrays

			PRJNA209591 Human DNA methylation
			profiles for the HBV vaccine responses study

			PRJNA381263 Human Gene Expression
			Patterns Associated with Experimental P.
			falciparum Infection

			PRJNA381264 Human Gene Expression
			Patterns Associated with Experimental P.
			falciparum Infection

			PRJNA369859 Human monocyte subsets are
			transcriptionally and functionally altered in aging
			in response to pattern recognition receptor
			agonists [ExVivo]

			PRJNA369860 Human monocyte subsets are
			transcriptionally and functionally altered in aging
			in response to pattern recognition receptor
			agonists [InVitro]

			PRJNA252948 Human responses to influenza
			vaccination

			PRJNA252949 Human responses to influenza
			vaccination

			PRJNA374963 Human tissue-resident memory
			T cells are defined by core transcriptional and
			functional signatures in lymphoid and mucosal
			sites

			PRJNA174747 Identification of genes critical
			for resistance to infection by West Nile virus
			using RNA-Seq analysis

			PRJNA191087 IFNa and IL4 DCs stimulated
			with microbial components for 6hr

			PRJNA191088 IFNa DCs and IL4 DCs exposed
			to H1N1, heat killed S. aureus, or heat killed S.
			enterica (HKSE) for 1h, 2h, 6h, 12h, or 24h

			PRJNA191089 IL4 DCs and monocytes
			stimulated by 13 human vaccines and LPS for
			6hr

			PRJNA243916 Immune response to MVA85A
			or placebo in BCG-vaccinated South African
			infants at day 1 post-vaccination

			PRJNA243915 Immune response to MVA85A
			or placebo in BCG-vaccinated South African
			infants at days 0 and 28 post-vaccination

			PRJNA109425 Immune response to the yellow
			fever vaccine 17D.

			PRJNA316868 Immunologic Effects of a
			Peptide Vaccine with Intralesional IFNgamma
			For Treatment of Melanoma

			PRJNA430293 Immunoprotective mechanisms
			and microbiota interplay in S. Typhi infection

			PRJNA430294 Immunoprotective mechanisms
			and microbiota interplay in S. Typhi infection

			PRJNA135065 Improved Innate and Adaptive
			Immunostimulation by Genetically Modified
			HIV-1 Protein Expressing NYVAC Vectors

			PRJNA391286 Increased adaptative immune
			response and proper feedback reguation
			protect against clinical Dengue

			PRJNA525416 Inflammatory Mediator
			Expression Associated With Antibody
			Response Induced by Live Attenuated vs
			Inactivated Influenza Virus Vaccine in Children.

			PRJNA186436 Influenza peptide reactivity
			within a cohort of age-stratified individuals pre
			and post vaccination with the 2008/2009
			trivalent influenza vaccine

			PRJNA322321 Influenza Vaccines Differentially
			Regulate the Interferon Response in Human
			Dendritic Cell Subsets [HumanHT-12 V4.0
			Beadchip Experiments]

			PRJNA322322 Influenza Vaccines Differentially
			Regulate the Interferon Response in Human
			Dendritic Cell Subsets [HumanWG-6 v3.0
			Beadchip Experiments]

			PRJNA486355 Initiation and Early Development
			of Three MPER-Directed Neutralizing Antibody
			Lineages from an HIV-1-Infected Individual

			PRJNA282140 Innate Immune Recognition of
			Bacterial Viability Instructs Human T follicular
			Helper Cell Differentiation

			PRJNA127659 Innate signature induced in
			human mDCs by dengue vaccine candidates

			PRJNA315699 Integrated transcriptomics and
			metabolomics profiling delineates early
			molecular correlates of immunity to herpes
			zoster vaccination in humans

			PRJNA517957 Interferon and inflammasome
			networks are associated with lower neutralizing
			antibody responses to Yellow Fever vaccination

			PRJNA273923 Interleukin-1- and Type I
			Interferon-Dependent Enhanced
			Immunogenicity of an NYVAC-HIV-1
			Env-Gag-Pol-Nef Vaccine Vector with Dual
			Deletions of Type I and Type II
			Interferon-Binding Proteins

			PRJNA111533 Knock-out of the nuclear
			localization in pp65 protein of Cytomegalovirus:
			biologic and immunologic effects

			PRJNA169614 Leukocyte transcript alterations
			in West-African girls following a booster
			vaccination with diphtheria-tetanus-pertussis
			vaccine

			PRJNA294051 Live Attenuated Tetravalent
			Dengue Vaccination in Non-Human Primates

			PRJNA275428 Malaria-associated atypical
			memory B cells exhibit markedly reduced B cell
			receptor signaling and effector function

			PRJNA347636 Maternal BCG scar is
			associated with enhanced infant
			proinflammatory responses

			PRJNA280773 Microarray analysis of
			IFN-response

			PRJNA136725 Microarray analysis of total naïve
			and YFV-17D specific CD8 T cells in humans

			PRJNA138273 Microarray screening of RNA
			samples from two human myeloma and two
			human lymphoma cell lines

			PRJNA219425 Molecular Hallmarks of
			Experimentally Acquired Immunity to Malaria
			[Pilot Study]

			PRJNA227074 Molecular Hallmarks of Naturally
			Acquired Immunity to Malaria

			PRJNA115011 Multiomics study to identify
			virulence factors of Rickettsia prowazekii
			revealed its adaptive mutation capabilities

			PRJNA382377 Next Generation Sequencing
			RNA Seq data from UKE Phase I rVSV ZEBOV
			vaccine clinical trial, from full blood samples on
			Days 0,1,3,7

			PRJNA227088 Novel Immunotherapy-Induced
			Tertiary Lymphoid Aggregates Accumulate as
			Intratumoral Nodal Structures of Immune
			Regulation in Pancreatic Cancer

			PRJNA260577 Nuclear PKCq binding to DNA
			in T lymphocytes.

			PRJNA139333 Oxygen regulation of
			immunogenicity in primary human glioma cells

			PRJNA420968 Paired TCR and transcriptome
			analysis of single T cells characterizes clonally
			expanded human conventional and
			unconventional CD8+ T cells

			PRJNA124911 PBMC expression profiles of
			BCG vaccine protected infants and of BCG
			vaccinated infants who develop tuberculosis
			disease

			PRJNA401959 Personal Neoantigen Cancer
			Vaccines

			PRJNA401960 Personal Neoantigen Cancer
			Vaccines

			PRJNA429518 Personalized NeoAntigen
			Cancer Vaccine with RT for Newly Diagnosed
			Glioblastoma

			PRJNA429519 Personalized NeoAntigen
			Cancer Vaccine with RT for Newly Diagnosed
			Glioblastoma

			PRJNA292927 Phenotypical and functional
			characterization of human skin dermal dendritic
			cells and Langerhans cells.

			PRJNA263206 Plasmablast response to
			influenza vaccines

			PRJNA270825 Plasmablast response to
			influenza vaccines - 2012

			PRJNA216951 Plasmablast Trafficking and
			Antibody Response in Influenza Vaccination

			PRJNA216953 Plasmablast Trafficking and
			Antibody Response in Influenza Vaccination

			PRJNA242624 Plasmid-free Chlamydia
			trachomatis elicit lowered inflammation, delayed
			apoptosis, and reduced chemoattractant
			expression in HeLa cells compared to
			plasmid-containing wild type

			PRJNA217432 Post-vaccination serum
			anti-glycan IgG antibodies of 113 subjects in a
			clinical trial of PROSTVAC-VF, a therapeutic
			cancer vaccine. (Dilution = 1:50)

			PRJNA217433 Post-vaccination serum
			anti-glycan IgG antibodies of 28 subjects in a
			clinical trial of PROSTVAC-VF, a therapeutic
			cancer vaccine. (Dilution = 1:50)

			PRJNA217435 Post-vaccination serum
			anti-glycan IgM antibodies of 28 subjects in a
			clinical trial of PROSTVAC-VF, a therapeutic
			cancer vaccine. (Dilution = 1:50)

			PRJNA217429 Post-vaccination serum
			anti-glycan total Ig antibodies of 113 subjects in
			a clinical trial of PROSTVAC-VF, a therapeutic
			cancer vaccine. (Dilution = 1:200)

			PRJNA217430 Post-vaccination serum
			anti-glycan total Ig antibodies of 28 subjects in
			a clinical trial of PROSTVAC-VF, a therapeutic
			cancer vaccine. (Dilution = 1:200)

			PRJNA217434 Post-vaccination serum
			anti-glycan total Ig antibodies of 28 subjects in
			a clinical trial of PROSTVAC-VF, a therapeutic
			cancer vaccine. (Dilution = 1:50)

			PRJNA493983 Precise tracking of
			vaccine-responding T-cell clones reveals
			convergent and personalized response in
			identical twins

			PRJNA280239 Probiotics to Enhance Influenza
			Vaccine Immunogenicity

			PRJNA280240 Probiotics to Enhance Influenza
			Vaccine Immunogenicity

			PRJNA294027 Probiotics to Enhance Influenza
			Vaccine Immunogenicity:Lactobacillus
			rhamnosus GG ATCC (LGG) as an immune
			adjuvant for influenza vaccination in the elderly

			PRJNA294028 Probiotics to Enhance Influenza
			Vaccine Immunogenicity:Lactobacillus
			rhamnosus GG ATCC (LGG) as an immune
			adjuvant for influenza vaccination in the elderly

			PRJNA286031 Probiotics to Enhance Influenza
			Vaccine Immunogenicity:Transcriptomic Profile
			of Whole Blood Cells from Elderly Subjects Fed
			Probiotic Lactobacillus rhamnosus GG ATCC
			53103 (LGG) in a Phase I Open Label Study.

			PRJNA286032 Probiotics to Enhance Influenza
			Vaccine Immunogenicity:Transcriptomic Profile
			of Whole Blood Cells from Elderly Subjects Fed
			Probiotic Lactobacillus rhamnosus GG ATCC
			53103 (LGG) in a Phase I Open Label Study.

			PRJNA113997 Profiling 11,639 genes in
			PBMCs from 2 donors: U133 A 2.0 Custom
			CDF Version 9

			PRJNA113999 Profiling 20,077 genes in 25
			vaccine recipients: U133 Plus 2.0, Custom CDF
			Version 9

			PRJNA448900 Protein microarray epitope
			mapping of monoclonal antibody 5H2 raised by
			human immunization with the 4CMenB vaccine
			formulation containing the fusion antigen
			NHBA-NMB1030.

			PRJNA189489 Real-time quantitative PCR
			analysis of microRNAs in human PBMC
			samples

			PRJNA392910 RNA-seq analysis of YFV-17D
			specific and total naive CD8 T cells in humans

			PRJNA475036 RNA-seq of HIV bnAb and
			control individuals PBMC

			PRJNA497243 RNA-Sequencing data of
			Varicella Zoster Virus (VZV)-infected human
			dermal fibroblasts (HDF)

			PRJNA343804 Safety and Immunogenicity of
			the Recombinant BCG Vaccine AERAS-422 in
			Healthy BCG-naïve Adults: A Randomized,
			Active-controlled, First-in-human Phase 1 Trial

			PRJNA342437 Safety and immunogenicity of
			the recombinant BCG vaccine VPM1002, in
			South African infants

			PRJNA148259 Segmentation and intensity
			estimation for microarray images with saturated
			pixels

			PRJNA490176 Selective expansion of myeloid
			and NK cells in humanized mice yields
			human-like vaccine responses (Experiment 1:
			RNA-seq)

			PRJNA490177 Selective expansion of myeloid
			and NK cells in humanized mice yields
			human-like vaccine responses (Experiment 2:
			scRNA-seq)

			PRJNA400331 Sequential inflammatory
			processes define human progression from M.
			tuberculosis infection to tuberculosis disease

			PRJNA478850 Spec-seq unveils transcriptional
			subpopulations of antibody-secreting cells
			following influenza vaccination

			PRJNA146547 Synthetic double stranded RNA
			reliably induces innate immunity similar to a live
			viral vaccine in humans

			PRJNA351258 Systems analysis of protective
			immune responses to RTS,S malaria
			vaccination in humans

			PRJNA129111 Systems analysis of the Merck
			Ad5/HIV vaccine reveals robust induction of a
			core innate immune gene network: in vitro
			analysis

			PRJNA129109 Systems analysis of the Merck
			Ad5/HIV vaccine reveals robust induction of a
			core innate immune gene network: in vivo
			analysis

			PRJNA302111 Systems biology of immunity to
			MF59-adjuvanted versus non-adjuvanted
			trivalent seasonal influenza vaccines in early
			childhood

			PRJNA400483 The comparsion of gene
			expression in ALVAC- and Ad5-infected human
			monocyte-derived dendritic cells

			PRJNA283108 The gene expression profile of
			peripheral blood mononuclear cells (PBMCs) of
			infants (6 to 11 months) immunized with an
			inactivated EV71 vaccine or placebo

			PRJNA315543 The Glioma-Infiltrating T Cell
			Receptor Repertoire

			PRJNA476425 The Immunogenetics of
			Measles Immunity

			PRJNA476426 The Immunogenetics of
			Measles Immunity

			PRJNA260966 The transcriptional profile of
			human CD8+ lung resident memory T-cells

			PRJNA301658 Time Course of Adults
			Vaccinated with Influenza TIV Vaccine during
			2009/10 Flu Season

			PRJNA301609 Time Course of Adults
			Vaccinated with Influenza TIV Vaccine during
			2010/11 Flu Season (FluCenter cohort)

			PRJNA301610 Time Course of Adults
			Vaccinated with Influenza TIV Vaccine during
			2010/11 Flu Season (HIPC cohort)

			PRJNA301608 Time Course of Adults
			Vaccinated with Influenza TIV Vaccine during
			2011/12 Flu Season

			PRJNA153823 Time Course of Young Adults
			Vaccinated with Influenza LAIV Vaccine during
			2008/09 Flu Season

			PRJNA153821 Time Course of Young Adults
			Vaccinated with Influenza TIV Vaccine during
			2007/08 Flu Season

			PRJNA153825 Time Course of Young Adults
			Vaccinated with Influenza TIV Vaccine during
			2008/09 Flu Season

			PRJNA227289 Time Course of Young Adults
			Vaccinated with Meningococcal MCV4 and
			MPSV4 Vaccines

			PRJNA260399 Transcription in a Jurkat cell
			model of T cell memory

			PRJNA341405 Transcription profiling of PfSPZ
			Malaria Vaccine trial subjects in a malaria
			endemic region

			PRJNA217400 Transcriptional analysis of
			human blood CXCR5+ CD4 T cell populations

			PRJNA217399 Transcriptional analysis of
			human tonsil Tfh cells

			PRJNA275222 Transcriptional profiling of
			HBV-naïve subjects before vaccination against
			Hepatitis A/B viruses, Diphtheria/Tetanus
			toxoids and Cholera.

			PRJNA412219 Transcriptional reprogramming
			of human CD4 T cells transitioning from active
			to memory state

			PRJNA392453 Transcriptional responses to
			oral live attenuated typhoid vaccines

			PRJNA219948 Transcriptome analysis of a
			clinical phase Ia Mycobacterium bovis BCG
			vaccination study (sex and age matched
			European (Caucasian) males, 25-35 years,
			performed in Germany)

			PRJNA219950 Transcriptome analysis of a
			clinical phase Ib Mycobacterium bovis BCG
			vaccination study (sex and age matched
			African males, 25-35 years, performed in
			South-Africa)

			PRJNA176482 Transcriptome Analysis of
			Human Peripheral Blood Mononuclear Cells
			Exposed to Lassa Virus and to the Reassortant
			ML29, a Vaccine Candidate

			PRJNA155831 Transcriptome profiles of
			mouse and human monocyte and dendritic cell
			subsets (human data)

			PRJNA454373 Transcriptomic profile of
			circulating CD4+ T cells from TCM and TEM
			memory compartments from donors
			vaccinated at birth either with whole or acellular
			Pertussis vaccine

			PRJNA262041 Transcriptomic profiling
			facilitates classification of response to influenza
			challenge

			PRJNA433844 Transcriptomic profiling
			following de novo hepatitis B vaccination
			reveals role of granulocytes in non-responders

			PRJNA406921 Transcriptomic profiling of
			RV144 trial participants after vaccination with
			ALVAC-HIV and AIDSVAX B/E. [rv144]

			PRJNA406919 Transcriptomic profiling of
			RV144 trial participants before and after
			vaccination with ALVAC-HIV and AIDSVAX
			B/E.[rv144pilot]

			PRJNA401818 Trigger-happy resident memory
			CD4+ T cells inhabit the human lungs.

			PRJNA226092 Trivalent Inactivated Influenza
			Vaccine (TIV) and Live Attenuated Influenza
			Vaccine (LAIV) Induce Different B cell and
			Transcriptional Responses in Children

			PRJNA317666 Vaccination and topical
			imiquimod treatment promote immune
			signatures in melanoma

			PRJNA278450 Vaccination increases the
			breadth and diversity of melanoma
			neoantigen-specific T cells

			PRJNA377938 VACCINATION STATUS
			AGAINST HEPATITIS B AMONG DOCTORS OF
			AYUB TEACHING HOSPITAL, ABBOTTABAD

			PRJNA106741 Vaccinia E3L mutant virus
			infected HeLa cell lines
			(langl-affy-human-215499)

			PRJNA93801 Varicella-zoster virus infection of
			human T cells and fibroblasts in vitro and
			SCIDhu skin xenografts in vivo.

			PRJNA301654 Viral Respiratory Pathogens
			Genetics

			PRJNA301655 Viral Respiratory Pathogens
			Genetics

			PRJNA383833 VT257_DengueVaccination

			PRJNA327545 Whole blood transcriptional
			analysis of vaccine combination administration
			in infants

			PRJNA128917 Whole blood transcriptional
			profiles of patients with active tuberculosis (TB)
			and other inflammatory and infectious diseases

			PRJNA304496 Whole genome DNA
			methylation analysis of human CD8 T cell
			specific for the Yellow fever virus vaccine

			PRJNA324714 Whole-Cell Cancer Vaccines
			Induce Large Antibody Responses to
			Carbohydrates and Glycoproteins

			PubMed
			32351942 Carbohydrate Conjugates in Vaccine
			Developments.

			32351814 Common CT Findings of Novel
			Coronavirus Disease 2019 (COVID-19): A Case
			Series.

			32351503 Low-Complexity Repetitive Epitopes
			of Plasmodium falciparum Are Decoys for
			Humoural Immune Responses.

			32346535 Hepatocellular Carcinoma
			Mechanisms Associated with Chronic HCV
			Infection and the Impact of Direct-Acting
			Antiviral Treatment.

			32346479 Type I interferon shapes the quantity
			and quality of the anti-Zika virus antibody
			response.

			32342015 Paediatric drugs trials in China.

			32336855 Voluntary vaccination: the pandemic
			effect.

			32336601 Arboviruses: A global public health
			threat.

			32328416 In Vivo Assembly of Nanoparticles
			Achieved through Synergy of Structure-Based
			Protein Engineering and Synthetic DNA
			Generates Enhanced Adaptive Immunity.

			32328406 Vaccines for SARS-CoV-2: Lessons
			from Other Coronavirus Strains.

			32328299 Development of Nested
			PCR-Heteroduplex Mobility Assay for
			Determination of Genetic Diversity in the Block
			2 Region of the Plasmodium falciparum
			Merozoite Surface Protein 1 Gene.

			32322567 Impact of China's Vaccine Incidents
			on the Operational Efficiency of Biopharmaceutical
			Companies.

			32322479 H1N1 with fatal viral septicemia in
			a normal child: A case report.

			32321154 DNA nanovaccines prepared using
			LemA antigen protect Golden Syrian hamsters
			against Leptospira lethal infection.

			32320825 Recent progress and challenges
			in drug development against COVID-19
			coronavirus (SARS-CoV-2) - an update on the
			status.

			32318665 Age-related rhesus macaque models
			of COVID-19.

			32318405 Global search trends on common
			vaccine-related information in English on the
			Internet.

			32318343 Multi-Infection Patterns and
			Co-infection Preference of 27 Human
			Papillomavirus Types Among 137,943
			Gynecological Outpatients Across China.

			32318055 Better Epitope Discovery, Precision
			Immune Engineering, and Accelerated Vaccine
			Design Using Immunoinformatics Tools.

			32313731 T cell receptor repertoire as a
			prognosis marker for heat shock protein peptide
			complex-96 vaccine trial against newly
			diagnosed glioblastoma.

			32313721 An innovative plasmacytoid dendritic
			cell line-based cancer vaccine primes and
			expands antitumor T-cells in melanoma patients
			in a first-in-human trial.

			32313545 A Modular Vaccine Platform
			Combining Self-Assembled Peptide Cages and
			Immunogenic Peptides.

			32313544 Viromimetic STING Agonist-Loaded
			Hollow Polymeric Nanoparticles for Safe and
			Effective Vaccination against Middle East Respiratory Syndrome
			Coronavirus.

			32309449 Therapeutic Effects of BCG
			Vaccination on Type 1 Diabetes Mellitus: A
			Systematic Review and Meta-Analysis of
			Randomized Controlled Trials.

			32309377 Association of survival and genomic
			mutation signature with immunotherapy in
			patients with hepatocellular carcinoma.

			32308382 Virus-Like Particles Presenting the
			FGF-2 Protein or Identified Antigenic Peptides
			Promoted Antitumor Immune Responses in
			Mice.

			32307593 Therapeutic strategies for critically
			ill patients with COVID-19.

			32300370 Can an effective SARS-CoV-2
			vaccine be developed for the older population?

			32300346 Immunodomination of Serotype-Specific
			CD4+ T-Cell Epitopes Contributed to the
			Biased Immune Responses Induced by a
			Tetravalent Measles-Vectored Dengue Vaccine.

			32299399 Addressing quadruple aims through
			primary care and public health collaboration:
			ten Canadian case studies.

			32298236 A murine model demonstrates
			capsule-independent adaptive immune
			protection in survivors of Klebsiella pneumoniae
			respiratory tract infection.

			32296581 Synthetic and immunological studies
			on the OCT4 immunodominant motif
			antigen-based anti-cancer vaccine.

			32294137 Baloxavir treatment of ferrets infected
			with influenza A(H1N1)pdm09 virus reduces
			onward transmission.

			32292586 Vaccine coverage within the first
			year of life and associated factors with
			incomplete immunization in a Brazilian birth
			cohort.

			32290844 Recombinant lipidated Zika virus
			envelope protein domain III elicits durable
			neutralizing antibody responses against Zika
			virus in mice.

			32289036 Molecular characterization of
			infectious bronchitis viruses isolated from
			broiler and layer chicken farms in Egypt during
			2012.

			32288985 Endemic Mycoses: What's New
			About Old Diseases?

			32288838 Promotion of seasonal
			influenza vaccination among staff in residential
			care homes for elderly in Hong Kong.

			32288582 Influenza and other emerging
			respiratory viruses.

			32288412 Dissection of SARS Coronavirus
			Spike Protein into Discrete Folded Fragments.

			32288210 Experiences from the 2014 outbreak
			of bluetongue in Greece.

			32288068 Operational issues and network
			effects in vaccine markets.

			32286302 Sex-specific innate immune selection
			of HIV-1 in utero is associated with increased
			female susceptibility to infection.

			32284877 Rapid detection of African swine fever
			virus using Cas12a-based portable paper
			diagnostics.

			32283298 A medicinal chemistry perspective
			of drug repositioning: Recent advances and
			challenges in drug discovery.

			32281989 Large community mumps outbreak
			in Manitoba, Canada, September 2016-December
			2018.

			32278821 Applying next-generation sequencing
			to unravel the mutational landscape in viral
			quasispecies.

			32278364 COVID-19 and risks to the supply
			and quality of tests, drugs, and vaccines.

			32275960 A human rights approach to
			understanding provider knowledge and attitudes
			toward the human papillomavirus vaccine in
			São Paulo, Brazil.

			32274287 Preparation and in vivo evaluation
			of glyco-gold nanoparticles carrying synthetic
			mycobacterial hexaarabinofuranoside.

			32274268 Prediction of antiviral drugs against
			African swine fever viruses based on
			protein-protein interaction analysis.

			32273703 O/W Nanoemulsion as an Adjuvant
			for an Inactivated H3N2 Influenza Vaccine:
			Based on Particle Properties and Mode of
			Carrying.

			32273253 Hospital pharmacists' pharmaceutical
			care for hospitalized patients with COVID-19:
			Recommendations and guidance from clinical
			experience.

			32272920 Valuing the cost of improving Chilean
			primary vaccination: a cost minimization analysis
			of a hexavalent vaccine.

			32270052 Assessment of PrEP eligibility and
			uptake among at-risk MSM participating in a
			HIV-1 vaccine feasibility cohort in coastal
			Kenya.

			32269766 In silico identification of vaccine
			targets for 2019-nCoV.

			32269728 Immunotherapy in anaplastic
			thyroid cancer.

			32269571 Preventing Infections by Encapsulated
			Bacteria Through Vaccine Prophylaxis in
			Inflammatory Bowel Disease.

			32269566 Induction of Cross-Reactive and
			Protective Antibody Responses After DNA
			Vaccination With MHCII-Targeted Stem Domain
			From Influenza Hemagglutinin.

			32265929 Rapid Induction and Maintenance
			of Virus-Specific CD8+ TEMRA and CD4+ TEM
			Cells Following Protective Vaccination Against
			Dengue Virus Challenge in Humans.

			32265861 Phylogeographic Dynamics of
			Influenza A(H9N2) Virus Crossing Egypt.

			32265852 Defeat Dengue and Zika Viruses
			With a One-Two Punch of Vaccine and Vector
			Blockade.

			32265850 Does Mucosal B1 Activation Result
			in the Accumulation of Peak IgM During Chronic
			Intrarectal SIVmac239 Exposure to Protect
			Chinese-Origin Rhesus Macaques From Disease
			Progression?

			32265332 A Chimeric Japanese Encephalitis
			Vaccine Protects against Lethal Yellow Fever
			Virus Infection without Inducing Neutralizing
			Antibodies.

			32265331 Single-Dose, Intranasal Immunization
			with Recombinant Parainfluenza Virus 5
			Expressing Middle East Respiratory Syndrome
			Coronavirus (MERS-CoV) Spike Protein Protects
			Mice from Fatal MERS-CoV Infection.

			32264948 Plasmodium vivax HAP2/GCS1
			gene exhibits limited genetic diversity among
			parasite isolates from the Greater Mekong
			Subregion.

			32259480 SARS-CoV-2 Vaccines: Status
			Report.

			32259477 Infection and Rapid Transmission
			of SARS-CoV-2 in Ferrets.

			32259020 Tackling human and animal health
			threats through innovative vaccinology in Africa.

			32258205 Getting Personal: How Childhood
			Vaccination Policies Shape the Landscape of
			Vaccine Exemptions.

			32258174 West Nile Virus Vaccine Design by
			T Cell Epitope Selection: In Silico Analysis of
			Conservation, Functional Cross-Reactivity with
			the Human Genome, and Population Coverage.

			32258066 Mycobacterium avium Subspecies
			paratuberculosis Drives an Innate Th17-Like
			T Cell Response Regardless of the Presence
			of Antigen-Presenting Cells.

			32257431 COVID-19 infection: Origin,
			transmission, and characteristics of human
			coronaviruses.

			32257152 Predictors of Epstein-Barr virus
			serostatus and implications for vaccine policy:
			A systematic review of the literature.

			32257048 Structure, dynamics and immunogenicity
			of a catalytically inactive CXC chemokine-degrading
			protease SpyCEP from Streptococcus
			pyogenes.

			32256488 Anti-Dengue ED3 Long-Term Immune
			Response With T-Cell Memory Generated
			Using Solubility Controlling Peptide Tags.

			32256005 Genomic profiling of Nipah virus
			using NGS driven RNA-Seq expression data.

			32255981 Prevalence and prevention of
			brucellosis in cattle in Lebanon.

			32255493 Early Induction of Cross-Reactive
			CD8+ T-Cell Responses in Tonsils After
			Live-Attenuated Influenza Vaccination in Children.

			32253068 Recommendations for
			coronavirus infection in rheumatic diseases
			treated with biologic therapy.

			32247050 Insight into 2019 novel coronavirus
			- an updated intrim review and lessons from
			SARS-CoV and MERS-CoV.

			32246076 Synthetic mycobacterial molecular
			patterns partially complete Freund's adjuvant.

			32245999 Streamlined selection of cancer
			antigens for vaccine development through
			integrative multi-omics and high-content cell
			imaging.

			32245497 Next-generation immuno-oncology
			agents: current momentum shifts in cancer
			immunotherapy.

			32241761 Infectious diseases in children and
			adolescents in China: analysis of national
			surveillance data from 2008 to 2017.

			32240273 New live attenuated tuberculosis vaccine
			MTBVAC induces trained immunity and confers
			protection against experimental lethal
			pneumonia.

			32240161 Non-typhoidal Salmonella bloodstream
			infections in Kisantu, DR Congo: Emergence
			of O5-negative Salmonella Typhimurium and
			extensive drug resistance.

			32238821 Combination therapy using human
			papillomavirus L1/E6/E7 genes and archaeosome:
			a nanovaccine confer immuneadjuvanting effects to
			fight cervical cancer.

			32238569 Enterotoxigenic Escherichia coli
			Heat-Stable Toxin Increases the Rate of Zinc
			Release from Metallothionein and Is a Zinc-
			and Iron-Binding Peptide.

			32235848 Modification of Adenovirus vaccine
			vector-induced immune responses by expression
			of a signalling molecule.

			32235097 Immune escape and immunotherapy
			of acute myeloid leukemia.

			32234468 The epidemiology, diagnosis and
			treatment of COVID-19.

			32233157 A Nationwide Survey on the Hospital
			Vaccination Policies in Korea.

			32229157 Practical Strategies Against the
			Novel Coronavirus and COVID-19-the Imminent
			Global Threat.

			32228600 Immunogenicity analysis of conserved
			fragments in Plasmodium ovale species
			merozoite surface protein 4.

			32226930 Pancreatic ductal adenocarcinoma
			immune microenvironment and immunotherapy
			prospects.

			32226727 Recombinant Plant Engineering for
			Immunotherapeutic Production.

			32226720 Respiratory virus-induced
			heterologous immunity: Part of the problem or
			part of the solution?

			32226718 Molecular Pathogenesis of
			Middle East Respiratory Syndrome (MERS)
			Coronavirus.

			32226716 Attenuation of Viruses by
			Large-Scale Recoding of their Genomes: the
			Selection Is Always Biased.

			32226479 Information sources and adoption of
			vaccine during pandemics.

			32226475 A simulation model for policy
			decision analysis: a case of pandemic influenza
			on a university campus.

			32226262 Identification of porcine reproductive
			and respiratory syndrome virus inhibitors
			through an oriented screening on natural
			products.

			32219057 The SARS-CoV-2 Vaccine Pipeline:
			an Overview.

			32219001 Pregnancy has a minimal impact on
			the acute transcriptional signature to
			vaccination.

			32219000 Nasal vaccine delivery attenuates
			brain pathology and cognitive impairment in
			tauopathy model mice.

			32218999 Immune predictors of oral
			poliovirus vaccine immunogenicity among
			infants in South India.

			32218997 CD4+ Th immunogenicity of the
			Ascaris spp. secreted products.

			32218995 Antibody response of a
			particle-inducing, liposome vaccine adjuvant
			admixed with a Pfs230 fragment.

			32218786 Multiplex Screening Assay for
			Identifying Cytotoxic CD8+ T Cell Epitopes.

			32218774 BCG as a Case Study for Precision
			Vaccine Development: Lessons From Vaccine
			Heterogeneity, Trained Immunity, and Immune
			Ontogeny.

			32218667 Systemic adjuvant therapy for adult
			patients at high risk for recurrent cutaneous or
			mucosal melanoma: an Ontario Health
			(Cancer Care Ontario) clinical practice guideline.

			32214728 Stepwise prediction and statistical
			screening: B-cell epitopes on neuraminidase of
			human avian H5N1 virus.

			32214722 Immune responses of a designed
			HIV-1 DNA vaccine on rhesus monkeys.

			32214708 Preparation, characterization and
			preliminary in vivo studies of inactivated
			SARS-CoV vaccine.

			32214571 A predictive decision-aid
			methodology for dynamic mitigation of influenza
			pandemics.

			32214567 Recent developments in the use of
			transgenic plants for the production of human
			therapeutics and biopharmaceuticals.

			32211394 How the Lack of Chitosan
			Characterization Precludes Implementation of
			the Safe-by-Design Concept.

			32211300 Prevalence of Cervical Cancer
			Screening and Awareness among Women in an
			Urban Community in South India-A Cross
			Sectional Study.

			32211251 Personal Opinions Seem to be the
			Major Contributor to the Influenza Vaccination
			Disparity in Sneedville, TN.

			32211185 Peptide arrays of three collections of
			human sera from patients infected with
			mosquito-borne viruses.

			32211184 Peptide arrays of three collections of
			human sera from patients infected with
			mosquito-borne viruses.

			32211030 Use of Microbiota to Fight
			Mosquito-Borne Disease.

			32210975 Epitope Mapping and Fine Specificity
			of Human T and B Cell Responses for Novel
			Candidate Blood-Stage Malaria Vaccine P27A.

			32210962 LXR Activation Induces a
			Proinflammatory Trained Innate
			Immunity-Phenotype in Human Monocytes.

			32210956 Novel Peptide-Based PD1
			Immunomodulators Demonstrate Efficacy in
			Infectious Disease Vaccines and Therapeutics.

			32210954 Engineered Tumor-Derived
			Extracellular Vesicles: Potentials in Cancer
			Immunotherapy.

			32206694 Structural, glycosylation and
			antigenic variation between 2019
			novel coronavirus (2019-nCoV) and SARS
			coronavirus (SARS-CoV).

			32206575 Chromosomal rearrangements and
			their neoantigenic potential in mesothelioma.

			32206153 Pharmacists as immunizers to
			Improve coverage and provider/recipient
			satisfaction: A prospective, Controlled
			Community Embedded Study with vaccineS
			with low coverage rates (the Improve ACCESS
			Study): Study summary and anticipated
			significance.

			32204792 Rejuvenating conventional dendritic
			cells and T follicular helper cell formation after
			vaccination.

			32201620 The global and regional burden of
			genital ulcer disease due to herpes simplex
			virus: a natural history modelling study.

			32201619 Seasonal variation in the
			non-specific effects of BCG vaccination on
			neonatal mortality: three randomised controlled
			trials in Guinea-Bissau.

			32201571 Peptide arrays incubated with three
			collections of human sera from patients
			infected with mosquito-borne viruses.

			32201499 Middle East respiratory syndrome:
			pathogenesis and therapeutic developments.

			32201449 Drug targets for corona virus: A
			systematic review.

			32195333 Clinical development of
			immunotherapies for HER2+ breast cancer: a
			review of HER2-directed monoclonal antibodies
			and beyond.

			32194996 An optimized purified inactivated
			Zika vaccine provides sustained
			immunogenicity and protection in cynomolgus
			macaques.

			32194995 The outbreak of SARS-CoV-2
			pneumonia calls for viral vaccines.

			32193487 Prediction of the Vaccine-derived
			Poliovirus Outbreak Incidence: A Hybrid
			Machine Learning Approach.

			32192427 Correction to: Computational
			assembly of a human Cytomegalovirus vaccine
			upon experimental epitope legacy.

			32191728 In vitro model for the assessment of
			human immune responses to subunit RSV
			vaccines.

			32191177 Human Papillomavirus Awareness,
			Vaccine Status, and Risk Factors in Female
			Emergency Patients.

			32190692 Use of Novaluron-Based Autocidal
			Gravid Ovitraps to Control Aedes Dengue
			Vector Mosquitoes in the District of Gampaha,
			Sri Lanka.

			32188428 Vaccination coverage with the
			pneumococcal and influenza vaccine among
			persons with chronic diseases in Shanghai,
			China, 2017.

			32185899 Why is Listeria monocytogenes such
			a potent inducer of CD8+ T-cells?

			32185253 A survey to evaluate the
			implementation of vaccine recommendations
			among rheumatologists practicing in Greece.

			32184837 In-vitro Transcribed mRNA Delivery
			Using PLGA/PEI Nanoparticles into Human
			Monocyte-derived Dendritic Cells.

			32183833 Characterization of two in vivo
			challenge models to measure functional activity
			of monoclonal antibodies to Plasmodium
			falciparum circumsporozoite protein.

			32183695 Cyclosporine a directly affects
			human and mouse b cell migration in vitro by
			disrupting a hIF-1 αdependent, o2 sensing,
			molecular switch.

			32181756 Safety, tolerability, and
			immunogenicity of influenza vaccination with a
			high-density microarray patch: Results from a
			randomized, controlled phase I clinical trial.

			32181014 Immune responses in liver and
			spleen against Plasmodium yoelii
			pre-erythrocytic stages in Swiss mice model.

			32176708 Biochemical and immunological
			characterization of an ETEC CFA/I adhesin
			cholera toxin B subunit chimera.

			32174920 Genetic Diversity of Human
			Rotavirus A Among Hospitalized Children
			Under-5 Years in Lebanon.

			32174903 Clinical Relevance and Molecular
			Pathogenesis of the Emerging Serotypes 22F
			and 33F of Streptococcus pneumoniae in
			Spain.

			32174754 Immunotherapy in
			soft-tissue sarcoma.

			32171262 The effects of health literacy in
			influenza vaccination competencies among
			community-dwelling older adults in Hong Kong.

			32170215 Higher admission rates and
			in-hospital mortality for acute
			type A aortic dissection during Influenza
			season: a single center experience.

			32170135 Establishment, optimisation and
			quantitation of a bioluminescent murine
			infection model of visceral leishmaniasis for
			systematic vaccine screening.

			32169871 Pre-existing inflammatory immune
			microenvironment predicts the clinical response
			of vulvar high-grade squamous intraepithelial
			lesions to therapeutic HPV16 vaccination.

			32161150 Comparative Molecular Biology
			Approaches for the Production of Poliovirus
			Virus-Like Particles Using Pichia pastoris.

			32158366 Ethics and etiquette in an
			emergency vaccine trial. The orchestration of
			compliance.

			32158356 Novel therapeutic strategies and
			perspectives for metastatic pancreatic cancer:
			vaccine therapy is more than just a theory.

			32158144 Serological evaluation for the current
			epidemic situation of foot and mouth disease
			among cattle and buffaloes in Egypt.

			32155183 Factors associated with hindering
			the acceptance of HPV vaccination among
			caregivers - A cross-sectional study in
			Argentina.

			32155152 Genetic evolution of influenza viruses
			among selected countries in Latin America,
			2017-2018.

			32154289 ERS International Congress, Madrid,
			2019: highlights from the Basic and
			Translational Science Assembly.

			32154279 Progress Toward Development of
			Effective and Safe African Swine Fever Virus
			Vaccines.

			32154194 Human Papillomavirus Vaccination in
			Male and Female Adolescents Before and After
			Kidney Transplantation: A Pediatric Nephrology
			Research Consortium Study.

			32153719 Community stakeholder
			engagement during a vaccine demonstration
			project in Nigeria: lessons on implementation of
			the good participatory practice guidelines.

			32153565 Current Challenges in the
			Identification of Pre-Erythrocytic Malaria
			Vaccine Candidate Antigens.

			32153559 A Potential Herbal Adjuvant
			Combined With a Peptide-Based Vaccine Acts
			Against HPV-Related Tumors Through
			Enhancing Effector and Memory T-Cell Immune
			Responses.

			32153315 Exact conditional maximized
			sequential probability ratio test adjusted for
			covariates.

			32150583 Structure and mechanism of
			monoclonal antibody binding to the junctional
			epitope of Plasmodium falciparum
			circumsporozoite protein.

			32150558 Transmission center and driving
			factors of hand, foot, and mouth disease in
			China: A combined analysis.

			32150536 Detecting critical slowing down in
			high-dimensional epidemiological systems.

			32150236 Association Between Rotavirus
			Vaccination and Type 1 Diabetes in Children.

			32149156 A Solution with Ginseng Saponins
			and Selenium as Vaccine Diluent to Increase
			Th1/Th2 Immune Responses in Mice.

			32148667 Cloning and sequencing of the
			ompL37 gene present in Leptospira
			interrogans, a surface protein in pathogenic
			leptospires.

			32144163 A New Humanized Mouse Model
			Mimics Humans in Lacking α-Gal Epitopes and
			Secreting Anti-Gal Antibodies.

			32142734 Sentinel surveillance of selected
			veterinary and public health pathogens in camel
			population originating from Southern Punjab
			province, Pakistan.

			32140565 Assessment of PrEP eligibility and
			uptake among at-risk MSM participating in a
			HIV-1 vaccine feasibility cohort in coastal
			Kenya.

			32140053 Differential effects of Th17 cytokines
			during the response of neutrophils to
			Burkholderia cenocepacia outer membrane
			protein A.

			32139945 When to vaccinate a fluctuating
			wildlife population: Is timing everything?

			32138748 Quantifying the economic cost of
			antibiotic resistance and the impact of related
			interventions: rapid methodological review,
			conceptual framework and recommendations
			for future studies.

			32134914 Pathogen transmission from
			vaccinated hosts can cause dose-dependent
			reduction in virulence.

			32134484 Preventing Infection by Human
			Cytomegalovirus.

			32134478 The Status of Vaccine Development
			Against the Human Cytomegalovirus.

			32134475 Review of Mathematical Models of
			Vaccination for Preventing
			Congenital Cytomegalovirus Infection.

			32134394 A Values-Tailored Web-Based
			Intervention for New Mothers to Increase Infant
			Vaccine Uptake: Development and Qualitative
			Study.

			32133048 Checkpoint blockade inhibitors
			enhances the effectiveness of a Listeria
			monocytogenes-based melanoma vaccine.

			32132997 The TLR5 Agonist Flagellin Shapes
			Phenotypical and Functional Activation of Lung
			Mucosal Antigen Presenting Cells in Neonatal
			Mice.

			32132648 Virus Like Particles (VLP) as
			multivalent vaccine candidate against
			Chikungunya, Japanese Encephalitis,
			Yellow Fever and Zika Virus.

			32131866 Efficacy, immunogenicity, and safety
			of IC43 recombinant Pseudomonas aeruginosa
			vaccine in mechanically ventilated intensive care
			patients-a randomized clinical trial.

			32131541 Co-Expression Network Analysis of
			Spleen Transcriptome in Rock Bream
			(Oplegnathus fasciatus) Naturally Infected with
			Rock Bream Iridovirus (RBIV).

			31254536 Comparison of the effects of
			bacteriophage-derived dsRNA and poly(I:C) on
			ex vivo cultivated peripheral blood mononuclear
			cells.

			31254409 Tuberculosis patients display a high
			proportion of CD8+ T cells with a high cytotoxic
			potential.

			31254384 Integer-Valued Functional Data
			Analysis for Measles Forecasting.

			31253850 Manassantin B shows antiviral
			activity against coxsackievirus B3 infection by
			activation of the STING/TBK-1/IRF3 signalling
			pathway.

			31253680 A vibrating mesh nebulizer as an
			alternative to the Collison 3-jet nebulizer for
			infectious disease aerobiology.

			31253447 An indirect comparison
			meta-analysis of AS03 and MF59 adjuvants in
			pandemic influenza A(H1N1)pdm09 vaccines.

			31253446 Influenza immunisation coverage
			from 2015 to 2017: A national study of adult
			patients from Australian general practice.

			31253186 Effect of mobile text message
			reminders on routine childhood vaccination: a
			systematic review and meta-analysis.

			31252609 Bioluminescent Ross River Virus
			Allows Live Monitoring of Acute and Long-Term
			Alphaviral Infection by In Vivo Imaging.

			31252553 Tuberculosis Progression Does Not
			Necessarily Equate with a Failure of Immune
			Control.

			31252151 Effectiveness of an education health
			programme about Middle East respiratory
			syndrome coronavirus tested during travel
			consultations.

			31252073 HPV vaccination in HIV infection.

			31252035 Characterization of skin blebs from
			intradermal jet injection: Ex-vivo studies.

			31251952 Plasmodium berghei sporozoite
			specific genes- PbS10 and PbS23/SSP3 are
			required for the development of
			Exo-erythrocytic Forms.

			31251790 Post Hepatitis B vaccination
			sero-conversion among health care workers in
			the Cape Coast Metropolis of Ghana.

			31251760 Development of experimental
			pneumococcal vaccine for mucosal
			immunization.

			31251748 From genomic to LC-MS/MS
			evidence: Analysis of PfEMP1 in Benin malaria
			cases.

			31251585 Selective Capture and Determination
			of Receptor-Binding Hemagglutinin in Influenza
			Vaccine Preparations Using a Coupled
			Receptor-Binding/RP-HPLC Assay.

			31251537 Protection Efficacy of a
			Recombinant Herpesvirus of Turkey Vaccine
			Against Infectious Laryngotracheitis Virus
			Administered In Ovo to Broilers at Three
			Standardized Doses.

			31251535 Study of Efficacy and Replication of
			Recombinant Vector Vaccines by Using Turkey
			Herpesvirus Combined with Other Marek's
			Disease Vaccines.

			Clinical Trials
			3996538 Vaccination Efficacy With Metformin
			in Older Adults

			3995953 Integrated Care Delivery of HIV
			Prevention and Treatment in AGYW in Zambia

			3993717 Solid Organ Transplant SHINGRIX

			3992872 A Phase 2 Open-label Study to
			Assess the Safety and Immunogenicity of an
			Alum-adjuvanted Chikungunya Virus-like
			Particle Vaccine (PXVX0317) in Prior Recipients
			of Other Alphavirus Vaccines

			3990493 A Study of Infusion of Autologous
			Melanoma Lysate Pulsed Dendritic Cells With
			Dengue Virus-1 #45AZ5 in Advanced
			Melanoma

			3989895 A Study of Dengue Virus-1 #45AZ5,
			in Advanced Melanoma

			3989102 Safety, Immunogenicity, and
			Protective Efficacy of Radiation Attenuated
			Plasmodium Falciparum NF54 Sporozoites
			(PfSPZ Vaccine) During Malaria Transmission
			Season in Healthy African Adult Women of
			Childbearing Potential in Mali

			3989050 Immunogenicity and Safety of
			Pneumococcal Vaccination in Patients Treated
			With Immune Checkpoint Inhibitors

			3987490 Usability of HPV Vaccine Reminders

			3984890 Vitamin D3 For CGD Patients With
			BCGosis/Itis

			3983616 Surveillance of Invasive
			Pneumococcal Infections in Adults (Excluding
			Meningitis)

			3982199 A Study of an Ad26.RSV.preF-based
			Regimen in the Prevention of Reverse
			Transcriptase Polymerase Chain Reaction
			(RT-PCR)-Confirmed Respiratory Syncytial Virus
			(RSV)-Mediated Lower Respiratory Tract
			Disease in Adults Aged 65 Years and Older

			3982069 Immunologic Response to FluMist vs.
			Flucelvax

			3981952 Salmonella Conjugates CVD 1000:
			Study of Responses to Vaccination With
			Trivalent Invasive Salmonella Disease Vaccine

			3979014 Nonavalent Prophylactic HPV Vaccine
			(GARDASIL9) After Local Conservative The
			NOVEL Trial

			3975127 Cervical Cytology - Do SMS
			Reminders Increase Participation in the Cervical
			Screening Programme?

			3972813 Optimizing HPV Vaccine Introduction
			in Shanghai, China

			3971669 Blood Donor CVD 5000

			3971370 Immunogenicity and Safety of A
			Lyophilized Purified Human Diploid Cell Rabies
			Vaccine .

			3971058 Immune Responses After a Booster
			Immunisation With IXIARO® in Elderly Compared
			to Young Individuals.

     		                         Embed       Tweet       Print